What's Happening?
Eli Lilly is introducing a new generation of GLP-1 drugs, including the recently FDA-approved oral tablet Foundayo (orforglipron), which is expected to significantly impact the food and beverage industry. These drugs, which are more accessible and effective,
are anticipated to expand the user base beyond the current one in ten American adults who use GLP-1 drugs like Wegovy and Ozempic. The introduction of oral tablets is particularly noteworthy as it addresses needle phobia and is easier to distribute. Additionally, Eli Lilly is developing a 'triple agonist' drug, Retatrutide, which targets multiple pathways to enhance weight loss and glucose control. This development is expected to drive competition and innovation in the food and beverage sector as companies adapt to the changing needs of GLP-1 users.
Why It's Important?
The introduction of new GLP-1 drugs is poised to reshape the food and beverage industry by creating a larger market for products tailored to the needs of GLP-1 users. As these drugs become more affordable and accessible, they are likely to reach a broader demographic, including middle-income and rural Americans, where obesity rates are higher. This shift will drive demand for food and beverage products that cater to weight loss and altered eating behaviors. The competition among pharmaceutical companies is expected to lower drug prices, making them more accessible to a wider audience. This could lead to significant changes in consumer preferences and product offerings in the food and beverage industry.
What's Next?
As new GLP-1 drugs enter the market, food and beverage manufacturers will need to closely monitor these developments and adapt their products to meet the evolving needs of GLP-1 users. The anticipated FDA decision on Retatrutide in 2027 or 2028 could further expand the market. Additionally, the introduction of Medicare coverage for certain GLP-1 drugs in 2026 will increase accessibility, potentially leading to a surge in demand for related food and beverage products. Companies will need to innovate and anticipate the preferences of new user segments to remain competitive.
